VIR FY 2019 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$711,000-18.1% YoY

Gross Profit

$711,000100.0% margin

Operating Income

-$178M-25032.2% margin

Net Income

-$175M-24568.6% margin

EPS (Diluted)

$-1.62

Cash Flow

Operating Cash Flow

-$130M

Free Cash Flow

-$139M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$512M

Total Liabilities

$88M

Stockholders' Equity

$424M

Cash & Equivalents

$109M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$711,000	$868,000	-18.1%
Gross Profit	$711,000	-$99M	+100.7%
Operating Income	-$178M	-$119M	-50.0%
Net Income	-$175M	-$116M	-50.7%